Vendor Neutral Archive & PACS Market by Product Type, Modality, Application, End User - Global Forecast to 2031

1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation and Regional Scope
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Stakeholders

2.1 Key Insights and Market Highlights
2.2 Key Market Participants: Mapping of Strategic Developments
2.3 Disruptive Trends Shaping Vna & Pacs Market
2.4 High-Growth Segments
2.5 Regional Snapshot: Market Size, Growth Rate, and Forecast

3.1 Attractive Opportunities for Vendor Neutral Archive (Vna) & Pacs Market
3.2 North America Vna Pacs Market, by End User and Country
3.3 Vendor Neutral Archive (Vna) & Pacs Market, by Country

4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Heightened Investments in Medical Imaging Technologies
4.2.1.2 Growing Demand for Streamlined Healthcare Data Management Solutions
4.2.1.3 Integration of Pacs/Vna With Electronic Medical Records (Emrs)
4.2.2 Restraints
4.2.2.1 High Initial Investment
4.2.2.2 Lack of Standardized Protocols and Interoperability Frameworks
4.2.3 Opportunities
4.2.3.1 Government Initiatives to Increase Penetration of AI in Medical Imaging
4.2.3.2 Increasing Medical Imaging Procedures and Large Imaging Data Silos
4.2.3.3 Rapid Uptake of Big Data in Healthcare
4.2.4 Challenges
4.2.4.1 Rising Security Concerns Related to Cloud-Based Image Processing and Analytics
4.2.4.2 Data Security Issues
4.3 Unmet Needs and White Spaces
4.4 Interconnected Markets and Cross-Sector Opportunities
4.5 Strategic Moves by Tier-1/2/3 Players

5.1 Porter’S Five Forces Analysis
5.1.1 Intensity of Competitive Rivalry
5.1.2 Bargaining Power of Suppliers
5.1.3 Bargaining Power of Buyers
5.1.4 Threat of New Entrants
5.1.5 Threat of Substitutes
5.2 Macroeconomics Indicators
5.2.1 Introduction
5.2.2 GDP Trends and Forecast
5.2.3 Trends in Global Healthcare It Industry
5.3 Value Chain Analysis
5.4 Ecosystem Mapping
5.5 Pricing Analysis
5.5.1 Average Selling Price (Asp) Trend of Vna and Pacs Solutions, by Product Type
5.5.2 Average Selling Price Trend, by Region
5.6 Key Conferences and Events, 2026-2027
5.7 Trends/Disruptions Impacting Customer Business
5.8 Investment and Funding Scenario
5.9 Case Study Analysis
5.9.1 Ambra Health Utilized AWS Cloud Services to Propel Worldwide Growth of Its Medical Imaging Platform
5.9.2 Nhs Trust Adopted Integration and Instant Data Access Offered by Synapps Vna to Establish Unified Platform for Storing and Managing Dicom Image Data
5.10 Impact of 2025 US Tariff Overview
5.10.1 Introduction
5.10.2 Key Tariff Rates
5.10.3 Price Impact Analysis
5.11 Impact on Country/Region
5.11.1 the US
5.11.2 Europe
5.11.3 APAC
5.12 Impact on End Use Industries
5.13 Conclusion

6.1 Key Emerging Technologies
6.1.1 Dicom (Digital Imaging and Communications in Medicine)
6.1.2 Enterprise Imaging Solutions
6.1.3 Cloud-Based Storage and Services
6.2 Complementary Technologies
6.2.1 Image Exchange Networks
6.2.2 Data Analytics and Business Intelligence
6.3 Adjacent Technologies
6.3.1 Health Information Exchange (Hie)
6.4 Patent Analysis
6.4.1 Insights: Jurisdiction and Top Applicant Analysis
6.5 Future Applications
6.5.1 AI-Enabled Enterprise Diagnostic Orchestration
6.5.2 Multi-Specialty Enterprise Imaging Repository
6.5.3 Imaging Data Lake for Clinical Research and Real-World Evidence
6.5.4 Cloud-Based Regional Image Exchange and Virtual Care Networks
6.5.5 Personalized and Longitudinal Imaging Intelligence

7.1 Regional Regulations and Compliance
7.1.1 Regulatory Bodies, Government Agencies, and Other Organizations
7.1.2 Regulations
7.1.2.1 US
7.1.2.2 Europe
7.1.2.3 China
7.1.2.4 Japan
7.1.2.5 India
7.1.3 Industry Standards

8.1 Introduction
8.2 Decision-Making Process
8.3 Buyer Stakeholders and Buying Evaluation Criteria
8.3.1 Key Stakeholders in Buying Process
8.3.2 Buying Criteria
8.4 Adoption Barriers & Internal Challenges
8.5 Unmet Needs From Various End-Use Industries
8.5.1 Unmet Needs
8.5.2 End-User Expectations
8.6 Market Profitability

9.1 Introduction
9.2 Vna
9.2.1 Department Vna
9.2.1.1 Phased Imaging Modernization Driving Vna Adoption and Interoperability Growth
9.2.2 Multi-Department Vna
9.2.2.1 Cross-Department Imaging Consolidation Driving Scalable Enterprise Data Platform Adoption
9.2.3 Multi-Site Vna
9.2.3.1 Cloud-Based Multi-Site Imaging Consolidation Enabling Scalable, Centralized Care Delivery
9.3 Pacs
9.3.1 Department Pacs
9.3.1.1 Rising Imaging Volumes and Workforce Shortages Driving Workflow-Centric Pacs Adoption
9.3.2 Multi-Department Pacs
9.3.2.1 Shared Imaging Platforms Reducing Silos and Enabling Cross-Specialty Collaboration
9.3.3 Multi-Site Pacs
9.3.3.1 Centralized Cloud Pacs Enabling Cross-Site Workload Balancing and Productivity Gains

10.1 Introduction
10.2 Ct
10.2.1 Rapid Rise in Need for Ct Examinations to Support Market Growth
10.3 Mammography
10.3.1 Rise in Number of Mammography Procedures to Drive Market Growth
10.4 Ultrasound
10.4.1 Rising Technological Advancement in Ultrasound Devices to Support Market Growth
10.5 Magnetic Resonance Imaging (Mri)
10.5.1 Mri Is Cost-Effective and Easily Available Compared to Pet
10.6 X-Ray
10.6.1 Rapid Adoption of X-Ray Imaging Compared to Other Modalities to Boost Market
10.7 Pet
10.7.1 Increasing Use of Nuclear Medicines to Support Popularity of Pet

11.1 Introduction
11.2 on-Premise Model
11.2.1 on-Premise Deployment Model Provides Healthcare Organizations With Great Control and Security Over Sensitive Patient Data
11.3 Cloud-Based Model
11.3.1 Technological Advancements in Diagnostic Imaging Modalities to Drive Cloud-Based Model’S Popularity
11.4 Hybrid Model
11.4.1 Unified Efficiency for Optimal Performance to Drive Hybrid Vna and Pacs Solutions

12.1 Introduction
12.2 Independent Vendor
12.2.1 Dominance of Independent Vendors to Capture Significant Market Share
12.3 Third-Party Vendor
12.3.1 Need for Innovative Solutions to Fuel Surge in Third-Party Vendors’ Presence in Market

13.1 Introduction
13.2 Cardiology
13.2.1 Rising Cases of Cardiac Disorders to Drive Market
13.3 Orthopedic
13.3.1 Growth in Cases of Arthritis to Support Market Growth
13.4 Oncology
13.4.1 Rise in Number of Cancer Cases to Drive Use of Vna and Pacs Solutions for Oncology
13.5 Neurology
13.5.1 Increasing Demand for Advanced Neurological Imaging Technologies to Spur Growth
13.6 Obstetrics & Gynecology
13.6.1 Use of 3D and 4D Imaging for Monitoring Fetus Growth and Diagnosing High-Risk Pregnancies to Drive Application of Vna and Pacs Solutions
13.7 Other Applications

14.1 Introduction
14.2 Hospitals & Clinics
14.2.1 Growing Need to Improve Profitability of Healthcare Services to Drive Use of Hcit in Hospitals
14.3 Diagnostic Centers
14.3.1 Popularity of Diagnostic Centers to Propel Use of Vna and Pacs Solutions
14.4 Ambulatory Surgery Centers
14.4.1 Increasing Number of Interventional Imaging Procedures to Support Use of Vna and Pacs Solutions in Ambulatory Surgery Centers
14.5 Other End Users

15.1 Introduction
15.2 North America
15.2.1 Macroeconomic Outlook for North America
15.2.2 US
15.2.2.1 Regulatory Interoperability Mandates and Cloud-First Enterprise Imaging Strategies
15.2.3 Canada
15.2.3.1 Pan-Canadian Interoperability Drive Opens Enterprise Imaging Investment Pipeline
15.3 Europe
15.3.1 Macroeconomic Outlook for Europe
15.3.2 Germany
15.3.2.1 Hospital Future Act Investment Cycle Accelerates Pacs and Vna Modernization
15.3.3 UK
15.3.3.1 Nhs Digital Diagnostic Programme and AI Mandate Catalyze Gbp 700M Imaging It Overhaul
15.3.4 France
15.3.4.1 Ségur Du Numérique Imaging Wave Drives Ris-Pacs Interoperability At National Scale
15.3.5 Italy
15.3.5.1 Pnrr-Funded Hospital Modernization Drives Pacs Replacement and Digital Imaging Upgrades
15.3.6 Spain
15.3.6.1 National Health System Digitization and Regional Imaging Network Expansion Drive Market Growth
15.3.7 Rest of Europe
15.4 Asia-Pacific
15.4.1 Macroeconomic Outlook for Asia-Pacific
15.4.2 Japan
15.4.2.1 Aging Society and Society 5.0 Strategy Drive Next-Generation Pacs Replacement Cycle
15.4.3 China
15.4.3.1 Healthy China 2030 and 14Th Five-Year Plan Drive National Emr and Imaging Informatization
15.4.4 India
15.4.4.1 Ayushman Bharat Digital Mission Creates National Imaging Data Infrastructure Demand
15.4.5 Rest of Asia-Pacific
15.5 Latin America
15.5.1 Macroeconomic Outlook for Latin America
15.5.2 Brazil
15.5.2.1 Sus Hospital Modernization and Private Sector AI Imaging Adoption Drive Regional Market Leadership
15.5.3 Mexico
15.5.3.1 Private Hospital Expansion and Public Sector Technology Modernization Open Pacs Growth Pathway
15.5.4 Rest of Latin America
15.6 Middle East & Africa
15.6.1 Macroeconomic Outlook for Middle East & Africa
15.6.2 GCC Countries
15.6.2.1 Vision 2030 and National Health Digitization Investments Accelerate Smart Hospital Imaging Deployments
15.6.3 Rest of Middle East & Africa

16.1 Overview
16.2 Key Players’ Strategies/Right to Win
16.2.1 Overview of Strategies Adopted by Key Players in Vendor Neutral Archive (Vna) & Pacs Market
16.3 Revenue Share Analysis
16.4 Market Share Analysis, 2025
16.5 Company Evaluation Matrix: Key Players, 2025
16.5.1 Stars
16.5.2 Emerging Leaders
16.5.3 Pervasive Players
16.5.4 Participants
16.5.5 Company Footprint: Key Players, 2025
16.5.5.1 Company Footprint
16.5.5.2 Product Footprint
16.5.5.3 Deployment Footprint
16.5.5.4 End User Footprint
16.5.5.5 Regional Footprint
16.6 Company Evaluation Matrix: Startups/SMEs, 2025
16.6.1 Progressive Companies
16.6.2 Responsive Companies
16.6.3 Dynamic Companies
16.6.4 Starting Blocks
16.6.5 Competitive Benchmarking: Startups/SMEs, 2025
16.6.5.1 Detailed List of Key Startups/SMEs
16.7 Company Valuation and Financial Metrics
16.8 Brand/Software Comparison
16.9 Competitive Scenario
16.9.1 Product Launches & Upgrades
16.9.2 Deals
16.9.3 Other Developments

17.1 Key Companies
17.1.1 Agfa-Gevaert Group
17.1.1.1 Business Overview
17.1.1.2 Solutions Offered
17.1.1.3 Recent Developments
17.1.1.3.1 Deals
17.1.1.4 The Analyst's View
17.1.1.4.1 Right to Win
17.1.1.4.2 Strategic Choices
17.1.1.4.3 Weaknesses & Competitive Threats
17.1.2 Fujifilm Holdings Corporation
17.1.2.1 Business Overview
17.1.2.2 Solutions Offered
17.1.2.3 Recent Developments
17.1.2.3.1 Deals
17.1.2.3.2 Other Developments
17.1.2.4 The Analyst's View
17.1.2.4.1 Right to Win
17.1.2.4.2 Strategic Choices
17.1.2.4.3 Weaknesses & Competitive Threats
17.1.3 Sectra Ab
17.1.3.1 Business Overview
17.1.3.2 Solutions Offered
17.1.3.3 The Analyst's View
17.1.3.3.1 Right to Win
17.1.3.3.2 Strategic Choices
17.1.3.3.3 Weaknesses & Competitive Threats
17.1.4 Ge Healthcare
17.1.4.1 Business Overview
17.1.4.2 Solutions Offered
17.1.4.3 Recent Developments
17.1.4.3.1 Product Launches
17.1.4.3.2 Deals
17.1.4.4 The Analyst's View
17.1.4.4.1 Right to Win
17.1.4.4.2 Strategic Choices
17.1.4.4.3 Weaknesses & Competitive Threats
17.1.5 Merative
17.1.5.1 Business Overview
17.1.5.2 Solutions Offered
17.1.5.3 Recent Developments
17.1.5.3.1 Deals
17.1.5.4 The Analyst's View
17.1.5.4.1 Key Strengths
17.1.5.4.2 Strategic Choices
17.1.5.4.3 Weaknesses & Competitive Threats
17.1.6 Koninklijke Philips N.V.
17.1.6.1 Business Overview
17.1.6.2 Solutions Offered
17.1.6.3 Recent Developments
17.1.6.3.1 Product Launches
17.1.6.3.2 Deals
17.1.7 Canon Medical Systems Corporation
17.1.7.1 Business Overview
17.1.7.2 Solutions Offered
17.1.7.3 Recent Developments
17.1.7.3.1 Deals
17.1.8 Paxerahealth
17.1.8.1 Business Overview
17.1.8.2 Solutions Offered
17.1.9 Novarad Corporation
17.1.9.1 Business Overview
17.1.9.2 Solutions Offered
17.1.10 Hyland Software, Inc.
17.1.10.1 Business Overview
17.1.10.2 Solutions Offered
17.1.10.3 Recent Developments
17.1.10.3.1 Deals
17.1.11 Siemens Healthcare Limited
17.1.11.1 Business Overview
17.1.11.2 Solutions Offered
17.1.11.3 Recent Developments
17.1.11.3.1 Deals
17.1.12 Bridgehead Software Ltd.
17.1.12.1 Business Overview
17.1.12.2 Solutions Offered
17.1.13 Canopy Partners
17.1.13.1 Business Overview
17.1.13.2 Solutions Offered
17.1.14 Creliohealth Inc.
17.1.14.1 Business Overview
17.1.14.2 Solutions Offered
17.1.15 Aspyra, LLC
17.1.15.1 Business Overview
17.1.15.2 Solutions Offered
17.1.16 Postdicom
17.1.16.1 Business Overview
17.1.16.2 Solutions Offered
17.1.17 Medicasoft
17.1.17.1 Business Overview
17.1.17.2 Solutions Offered
17.1.18 Esaote Spa
17.1.18.1 Business Overview
17.1.18.2 Solutions Offered
17.1.18.3 Recent Developments
17.1.18.3.1 Product Launches
17.1.19 Visus Health It GmbH
17.1.19.1 Business Overview
17.1.19.2 Solutions Offered
17.2 Other Players
17.2.1 Advahealth Solutions
17.2.2 Softteam Solutions Pvt. Ltd.
17.2.3 Aro Systems
17.2.4 Central Data Networks
17.2.5 Onepacs
17.2.6 Dedalus Spa.

18.1 Research Approach
18.1.1 Secondary Research
18.1.1.1 Key Data From Secondary Sources
18.1.2 Primary Research
18.1.2.1 Primary Sources
18.1.2.2 Key Data From Primary Sources
18.1.2.3 Breakdown of Primary Interviews
18.1.2.4 Insights From Primary Experts
18.2 Research Methodology Design
18.3 Market Size Estimation
18.4 Data Triangulation
18.5 Research Assumptions
18.6 Research Limitations
18.6.1 Methodology-Related
18.6.2 Scope-Related
18.7 Risk Assessment

19.1 Discussion Guide
19.2 Knowledgestore: The Subscription Portal
19.3 Customization Options
19.4 Related Reports
19.5 Author Details

Table 1 Exchange Rates Utilized for Conversion to USD
Table 2 Impact of Porter’S Five Forces on Vendor Neutral Archive (Vna) & Pacs Market
Table 3 Vendor Neutral Archive (Vna) & Pacs Market: Role in Ecosystem
Table 4 Average Selling Price of Pacs Solutions, by Product Type (USD)
Table 5 Average Selling Price of Vna Solutions, by Product Type (USD)
Table 6 Key Conferences and Events, 2026-2027
Table 7 Jurisdiction Analysis of Top Applicant Countries for AI in Telehealth & Telemedicine
Table 8 List of Patents/Patent Applications, 2015-2025
Table 9 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 12 RoW: Regulatory Bodies, Government Agencies, and Other Organizations
Table 13 Influence of Stakeholders on Buying Process of Four End Users
Table 14 Key Buying Criteria for Four End Users
Table 15 Unmet Needs in Vendor Neutral Archive (Vna) & Pacs Market
Table 16 End-User Expectations in Vendor Neutral Archive (Vna) & Pacs Market
Table 17 Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 18 Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 19 Vendor Neutral Archive (Vna) Market, by Country/Region, 2024-2031 (USD Million)
Table 20 Department Vendor Neutral Archive (Vna) Market, by Country/Region, 2024-2031 (USD Million)
Table 21 Multi-Department Vendor Neutral Archive (Vna) Market, by Country/Region, 2024-2031 (USD Million)
Table 22 Multi-Site Vendor Neutral Archive (Vna) Market, by Country/Region, 2024-2031 (USD Million)
Table 23 Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 24 Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 25 Department Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 26 Multi-Department Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 27 Multi-Site Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 28 Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 29 Vendor Neutral Archive (Vna) & Pacs Market for Ct, by Country/Region, 2024-2031 (USD Million)
Table 30 Vendor Neutral Archive (Vna) & Pacs Market for Mammography, by Country/Region, 2024-2031 (USD Million)
Table 31 Vendor Neutral Archive (Vna) & Pacs Market for Ultrasound, by Country/Region, 2024-2031 (USD Million)
Table 32 Vendor Neutral Archive (Vna) & Pacs Market for Magnetic Resonance Imaging (Mri), by Country/Region, 2024-2031 (USD Million)
Table 33 Vendor Neutral Archive (Vna) & Pacs Market for X-Ray, by Country/Region, 2024-2031 (USD Million)
Table 34 Vendor Neutral Archive (Vna) & Pacs Market for Pet, by Country/Region, 2024-2031 (USD Million)
Table 35 Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 36 on-Premise Vendor Neutral Archive (Vna) & Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 37 Cloud-Based Vendor Neutral Archive (Vna) & Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 38 Hybrid Vendor Neutral Archive (Vna) & Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 39 Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 40 Independent Vendor Neutral Archive (Vna) & Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 41 Third-Party Vendor Neutral Archive (Vna) & Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 42 Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 43 Vendor Neutral Archive (Vna) & Pacs Market for Cardiology Applications, by Country/Region, 2024-2031 (USD Million)
Table 44 Vendor Neutral Archive (Vna) & Pacs Market for Orthopedic Applications, by Country/Region, 2024-2031 (USD Million)
Table 45 Vendor Neutral Archive (Vna) & Pacs Market for Oncology Applications, by Country/Region, 2024-2031 (USD Million)
Table 46 Vendor Neutral Archive (Vna) & Pacs Market for Neurology Applications, by Country/Region, 2024-2031 (USD Million)
Table 47 Vendor Neutral Archive (Vna) & Pacs Market for Obstetrics and Gynecology Applications, by Country/Region, 2024-2031 (USD Million)
Table 48 Vendor Neutral Archive (Vna) & Pacs Market for Other Applications, by Country/Region, 2024-2031 (USD Million)
Table 49 Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 50 Vendor Neutral Archive (Vna) & Pacs Market for Hospitals & Clinics, by Country/Region, 2024-2031 (USD Million)
Table 51 Vendor Neutral Archive (Vna) & Pacs Market for Diagnostic Centers, by Country/Region, 2024-2031 (USD Million)
Table 52 Vendor Neutral Archive (Vna) & Pacs Market for Ambulatory Surgical Centers, by Country/Region, 2024-2031 (USD Million)
Table 53 Vendor Neutral Archive (Vna) & Pacs Market for Other End Users, by Country/Region, 2024-2031 (USD Million)
Table 54 Vendor Neutral Archive (Vna) & Pacs Market, by Region, 2024-2031 (USD Million)
Table 55 North America: Vendor Neutral Archive (Vna) & Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 56 North America: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 57 North America: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 58 North America: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 59 North America: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 60 North America: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 61 North America: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 62 North America: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 63 North America: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 64 US: Key Macro Indicators
Table 65 US: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 66 US: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 67 US: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 68 US: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 69 US: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 70 US: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 71 US: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 72 US: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 73 Canada: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 74 Canada: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 75 Canada: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 76 Canada: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 77 Canada: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 78 Canada: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 79 Canada: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 80 Canada: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 81 Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 82 Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 83 Europe: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 84 Europe: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 85 Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 86 Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 87 Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 88 Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 89 Europe: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 90 Germany: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 91 Germany: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 92 Germany: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 93 Germany: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 94 Germany: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 95 Germany: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 96 Germany: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 97 Germany: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 98 UK: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 99 UK: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 100 UK: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 101 UK: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 102 UK: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 103 UK: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 104 UK: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 105 UK: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 106 France: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 107 France: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 108 France: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 109 France: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 110 France: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 111 France: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 112 France: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 113 France: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 114 Italy: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 115 Italy: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 116 Italy: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 117 Italy: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 118 Italy: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 119 Italy: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 120 Italy: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 121 Italy: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 122 Spain: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 123 Spain: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 124 Spain: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 125 Spain: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 126 Spain: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 127 Spain: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 128 Spain: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 129 Spain: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 130 Rest of Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 131 Rest of Europe: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 132 Rest of Europe: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 133 Rest of Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 134 Rest of Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 135 Rest of Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 136 Rest of Europe: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 137 Rest of Europe: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 138 Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 139 Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 140 Asia-Pacific: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 141 Asia-Pacific: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 142 Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 143 Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 144 Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 145 Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 146 Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 147 Japan: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 148 Japan: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 149 Japan: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 150 Japan: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 151 Japan: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 152 Japan: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 153 Japan: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 154 Japan: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 155 China: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 156 China: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 157 China: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 158 China: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 159 China: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 160 China: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 161 China: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 162 China: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 163 India: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 164 India: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 165 India: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 166 India: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 167 India: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 168 India: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 169 India: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 170 India: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 171 Rest of Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 172 Rest of Asia-Pacific: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 173 Rest of Asia-Pacific: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 174 Rest of Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 175 Rest of Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 176 Rest of Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 177 Rest of Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 178 Rest of Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 179 Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 180 Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 181 Latin America: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 182 Latin America: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 183 Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 184 Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 185 Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 186 Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 187 Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 188 Brazil: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 189 Brazil: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 190 Brazil: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 191 Brazil: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 192 Brazil: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 193 Brazil: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 194 Brazil: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 195 Brazil: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 196 Mexico: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 197 Mexico: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 198 Mexico: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 199 Mexico: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 200 Mexico: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 201 Mexico: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 202 Mexico: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 203 Mexico: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 204 Rest of Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 205 Rest of Latin America: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 206 Rest of Latin America: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 207 Rest of Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 208 Rest of Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 209 Rest of Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 210 Rest of Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 211 Rest of Latin America: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 212 Middle East & Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Country/Region, 2024-2031 (USD Million)
Table 213 Middle East & Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 214 Middle East & Africa: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 215 Middle East & Africa: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 216 Middle East & Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 217 Middle East & Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 218 Middle East & Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 219 Middle East & Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 220 Middle East & Africa: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 221 GCC Countries: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 222 GCC Countries: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 223 GCC Countries: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 224 GCC Countries: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 225 GCC Countries: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 226 GCC Countries: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 227 GCC Countries: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 228 GCC Countries: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 229 Rest of Middle East and Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 230 Rest of Middle East and Africa: Vendor Neutral Archive (Vna) Market, by Product Type, 2024-2031 (USD Million)
Table 231 Rest of Middle East and Africa: Pacs Market, by Product Type, 2024-2031 (USD Million)
Table 232 Rest of Middle East and Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Modality, 2024-2031 (USD Million)
Table 233 Rest of Middle East and Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Deployment Model, 2024-2031 (USD Million)
Table 234 Rest of Middle East and Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Vendor Type, 2024-2031 (USD Million)
Table 235 Rest of Middle East and Africa: Vendor Neutral Archive (Vna) & Pacs Market, by Application, 2024-2031 (USD Million)
Table 236 Rest of Middle East and Africa: Vendor Neutral Archive (Vna) & Pacs Market, by End User, 2024-2031 (USD Million)
Table 237 Overview of Strategies Adopted by Key Players in Vendor Neutral Archive (Vna) & Pacs Market, January 2023-April 2026
Table 238 Vendor Neutral Archive (Vna) & Pacs Market: Degree of Competition
Table 239 Vendor Neutral Archive (Vna) & Pacs Market: Product Footprint, 2025
Table 240 Vendor Neutral Archive (Vna) & Pacs Market: Deployment Footprint, 2025
Table 241 Vendor Neutral Archive (Vna) & Pacs Market: End User Footprint, 2025
Table 242 Vendor Neutral Archive (Vna) & Pacs Market: Regional Footprint, 2025
Table 243 Vendor Neutral Archive (Vna) & Pacs Market: Detailed List of Key Startups/SMEs, 2025
Table 244 Vendor Neutral Archive (Vna) & Pacs Market: Competitive Benchmarking of Startups/SMEs, 2025
Table 245 Vendor Neutral Archive (Vna) & Pacs Market: Product Launches & Upgrades, January 2023-April 2026
Table 246 Vendor Neutral Archive (Vna) & Pacs Market: Deals, January 2023-April 2026
Table 247 Vendor Neutral Archive (Vna) & Pacs Market: Other Developments, January 2023-April 2026
Table 248 Agfa-Gevaert Group: Business Overview
Table 249 Agfa-Gevaert Group: Solutions Offered
Table 250 Agfa-Gevaert Group: Deals
Table 251 Fujifilm Holdings Corporation: Company Overview
Table 252 Fujifilm Holdings Corporation: Solutions Offered
Table 253 Fujifilm Holdings Corporation: Deals
Table 254 Fujifilm Holdings Corporation: Other Developments
Table 255 Sectra Ab: Business Overview
Table 256 Sectra Ab: Solutions Offered
Table 257 Ge Healthcare: Business Overview
Table 258 Ge Healthcare: Solutions Offered
Table 259 Ge Healthcare: Products Launches
Table 260 Ge Healthcare: Deals
Table 261 Merative: Business Overview
Table 262 Merative: Solutions Offered
Table 263 Merative: Deals
Table 264 Koninklijke Philips N.V.: Business Overview
Table 265 Koninklijke Philips N.V.: Solutions Offered
Table 266 Koninklijke Philips N.V.: Product Launches
Table 267 Koninklijke Philips N.V.: Deals
Table 268 Canon Medical Systems Corporation: Company Overview
Table 269 Canon Medical Systems Corporation: Solutions Offered
Table 270 Canon Medical Systems Corporation: Deals
Table 271 Paxerahealth: Business Overview
Table 272 Paxerahealth: Solutions Offered
Table 273 Novarad Corporation: Business Overview
Table 274 Novarad Corporation: Solutions Offered
Table 275 Hyland Software, Inc.: Business Overview
Table 276 Hyland Software, Inc.: Solutions Offered
Table 277 Hyland Software, Inc.: Deals
Table 278 Siemens Healthcare Limited: Business Overview
Table 279 Siemens Healthcare Limited: Solutions Offered
Table 280 Siemens Healthcare Limited: Deals
Table 281 Bridgehead Software Ltd.: Business Overview
Table 282 Bridgehead Software Ltd.: Solutions Offered
Table 283 Canopy Partners: Business Overview
Table 284 Canopy Partners: Solutions Offered
Table 285 Creliohealth Inc.: Business Overview
Table 286 Creliohealth Inc.: Solutions Offered
Table 287 Aspyra, LLC: Business Overview
Table 288 Aspyra, LLC: Solutions Offered
Table 289 Postdicom: Business Overview
Table 290 Postdicom: Solutions Offered
Table 291 Medicasoft: Business Overview
Table 292 Medicasoft: Solutions Offered
Table 293 Esaote Spa.: Business Overview
Table 294 Esaote Spa: Solutions Offered
Table 295 Esaote Spa: Product Launches
Table 296 Visus Health It GmbH: Business Overview
Table 297 Visus Health It GmbH: Solutions Offered

Figure 1 Study Years Considered
Figure 2 Market Scenario
Figure 3 Global Vendor Neutral Archive (Vna) & Pacs Market, 2024-2031 USD Million)
Figure 4 Major Strategies Adopted by Key Players in Vendor Neutral Archive (Vna) & Pacs Market
Figure 5 Disruptions Influencing Growth of Vendor Neutral Archive (Vna) & Pacs Market
Figure 6 High-Growth Segments in Vendor Neutral Archive (Vna) & Pacs Market
Figure 7 Asia-Pacific to Be Fastest-Growing Region During Forecast Period
Figure 8 Expansion of Enterprise Imaging & Multi-Site Healthcare Networks Fueling Demand in Vendor Neutral Archive (Vna) & Pacs Market
Figure 9 Hospitals & End Users and US Accounted for Largest Respective Shares in 2025
Figure 10 India to Exhibit Fastest Growth During Forecast Period
Figure 11 Vendor Neutral Archive (Vna) & Pacs Market: Drivers, Restraints, Opportunities, and Challenges
Figure 12 Vendor Neutral Archive (Vna) & Pacs Market: Porter’S Five Forces Analysis
Figure 13 Vendor Neutral Archive (Vna) & Pacs Market: Value Chain Analysis
Figure 14 Vendor Neutral Archive (Vna) & Pacs Market: Ecosystem Mapping
Figure 15 Trends/Disruptions Impacting Customers’ Businesses
Figure 16 Vendor Neutral Archive (Vna) & Pacs Market: Investment and Funding Scenario, 2022-2025 (USD Million)
Figure 17 Jurisdiction and Top Applicant Analysis in Vendor Neutral Archive (Vna) & Pacs Market, January 2022-May 2025
Figure 18 Top Applicants and Owners (Companies/Institutions) for Vna and Pacs, January 2015 to May 2025
Figure 19 Influence of Stakeholders on Buying Process of Four End Users
Figure 20 Key Buying Criteria for Four End Users
Figure 21 North America: Vendor Neutral Archive (Vna) & Pacs Market Snapshot
Figure 22 UK: Count of Diagnostic Imaging Activity on Nhs Patients, January 2022-January 2023 (Million)
Figure 23 Asia-Pacific: Vendor Neutral Archive (Vna) & Pacs Market Snapshot
Figure 24 Revenue Analysis of Key Players in Vendor Neutral Archive (Vna) & Pacs Market, 2021-2025 (USD Million)
Figure 25 Vendor Neutral Archive (Vna) & Pacs Market: Market Share Analysis (2025)
Figure 26 Vendor Neutral Archive (Vna) & Pacs Market: Company Evaluation Matrix (Key Players), 2025
Figure 27 Vendor Neutral Archive (Vna) & Pacs Market: Company Footprint, 2025
Figure 28 Vendor Neutral Archive (Vna) & Pacs Market: Company Evaluation Matrix (Startups/SMEs), 2025
Figure 29 Ev/EBITDA of Key Vendors, 2026
Figure 30 Year-to-Date (YTD) Price Total Return and 5-Year Stock Beta of Vna and Pacs Vendors, 2026
Figure 31 Vendor Neutral Archive (Vna) & Pacs Market: Brand/Software Comparative Analysis
Figure 32 Agfa-Gevaert Group: Company Snapshot
Figure 33 Fujifilm Holdings Corporation: Company Snapshot
Figure 34 Sectra Ab: Company Snapshot
Figure 35 Ge Healthcare: Company Snapshot
Figure 36 Koninklijke Philips N.V.: Company Snapshot
Figure 37 Canon Medical Systems Corporation: Company Snapshot
Figure 38 Siemens Healthcare Limited: Company Snapshot
Figure 39 Research Design
Figure 40 Research Methodology: Hypothesis Building
Figure 41 Bottom-Up Approach
Figure 42 Top-Down Approach
Figure 43 Cagr Projections From Analysis of Market Drivers, Restraints, Opportunities, and Challenges
Figure 44 Cagr Projections: Supply-Side Analysis
Figure 45 Data Triangulation